0001496558-15-000001.txt : 20150402 0001496558-15-000001.hdr.sgml : 20150402 20150402151806 ACCESSION NUMBER: 0001496558-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150402 DATE AS OF CHANGE: 20150402 EFFECTIVENESS DATE: 20150402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clinical Ink, Inc. CENTRAL INDEX KEY: 0001496558 IRS NUMBER: 272987645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-237218 FILM NUMBER: 15747090 BUSINESS ADDRESS: STREET 1: 100 N. CHERRY STREET, STE 520 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 BUSINESS PHONE: 336-714-7402 MAIL ADDRESS: STREET 1: 100 N. CHERRY STREET, STE 520 CITY: WINSTON-SALEM STATE: NC ZIP: 27101 D 1 primary_doc.xml X0707 D LIVE 0001496558 Clinical Ink, Inc. 525 Vine Street, Suite 130 WINSTON-SALEM NC NORTH CAROLINA 27101 336-714-7402 DELAWARE Clinical Ink, LLC None Corporation true Edward S. Seguine 525 Vine Street, Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Executive Officer Director Promoter Douglas E. Pierce, Jr. 525 Vine Street, Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Executive Officer Director Promoter Philip RS Waugh, Jr. 525 Vine Street, Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Robert Kniejski 525 Vine Street, Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Director Matt King c/o FCA Venture Partners 5314 Maryland Way, Suite 100 Brentwood TN TENNESSEE 37027 Director Todd Foley c/o MPM Capital 200 Clarenden Street, 54th Floor Boston MA MASSACHUSETTS 02116 Director Brad Geesaman c/o MPM Capital 200 Clarenden Street, 54th Floor Boston MA MASSACHUSETTS 02116 Director Ansbert Gadicke c/o MPM Capital 200 Clarenden Street, 54th Floor Boston MA MASSACHUSETTS 02116 Director Morana Jovan-Embiricos c/o Charles Mia Limited 39 St. James's Place London X0 UNITED KINGDOM SW1A 1NS Director Joe Schmidt 525 Vine Street, Suite 130 Winston-Salem NC NORTH CAROLINA 27101 Executive Officer Other $1,000,001 - $5,000,000 06b false 2015-03-19 false true true There was a merger of two entities and some stock was issued in connection with the merger. A new round of financing was also obtained in connection with the merger. 0 9860223 9860223 0 false 21 0 0 0 false Clinical Ink, Inc. Douglas E. Pierce, Jr. Douglas E. Pierce, Jr. President 2015-04-02